Ziihera (Zanidatamab-hrii)

Ziihera (zanidatamab-hrii) is a bispecific HER2-directed antibody used in adults diagnosed with biliary tract cancer (BTC). This is for patients who are HER2-positive (IHC 3+), have received prior treatment, and are inoperable or have metastatic disease.

This approval is based on the results of clinical trials which included efficacy of the medicine, response rates (RR), and hospital stays. If there are further studies, full approval may be obtained.

Recommended Dosage: The recommended dosage of Zanidatamab-hrii is 20 mg/kg, administered as an intravenous (IV) infusion once every 2 weeks until there is evidence of disease progression or unacceptable toxicity.
If a planned dose is delayed or missed, administer the missed dose as quickly as possible; do not wait until the next planned dose. Adjust the administration schedule to maintain a 2-week interval between doses.

• The use of Zanidatamab-hrii may lead to some heart complications which include, diminished cardiac output. Therefore, regular cardiac function assessment should be done. Make sure to tell your healthcare provider (HCP) if you have prior heart issues or have experienced unexplained breathlessness.
• Infusion-related reactions such as fever, hypotension, and chills may occur. Some patients might show symptoms during and/or after infusion such as low temperature. Monitor the patient and notify your doctor if any of these side effects occur.
• Frequent diarrhea is also an adverse effect of the medication that may cause dehydration and electrolyte loss. Drink lots of water, and if diarrhea persists or becomes severe, see a physician to avoid further dehydration or electrolyte imbalance.
• The use of Zanidatamab-hrii 300 mg injection during pregnancy has been shown to have adverse effects on fetus development. The use of the medicine is contraindicated in pregnancy. Effective contraceptive measures should be adopted by women of reproductive age during treatment and for a period after the therapy.
• Medication can get transferred into milk from mothers during lactation and lead to some side effects on infants. Therefore, it is best not to breastfeed during the period of therapy and for a while after completion. Discuss with your physician for further guidance.

What documents are required to import ZIIHERA to India?

ZIIHERA (zanidatamab-hrii) injections can be imported by patients or government hospitals on the name of the patients only.

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is ZIIHERA available in India?

ZIIHERA (zanidatamab-hrii injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Ziihera in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait,
• Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada,
• Europe, and Australia
• Ensuring 100% transparency.

ZIIHERA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of ZIIHERA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Ziihera 300 mg injections price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source ZIIHERA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Ziihera®?

Zanidatamab-hrii is a Generic Name for the trade name drug Ziihera®.

What is the Manufacturer's Name of Ziihera®?

Ziihera® is manufactured by Jazz Pharmaceuticals.

Is Ziihera® approved by the FDA?

Yes, Ziihera® is approved by the FDA. Date of first approval: November 20, 2024.

What is the dosage and form of Ziihera® supplied?

Ziihera is supplied for injection: 300 mg lyophilized powder in a single-dose vial intravenous (IV) use.

What are the most common side effects of Ziihera® 300 mg injections?

The most common side effects of Ziihera® are abdominal pain, diarrhea, infusion-related reactions, and fatigue.

How much does Ziihera® 300 mg injection cost in India?

Prices of Ziihera 300 mg may fluctuate over time because of market dynamics and regulatory changes. To get the most transparent Ziihera 300 mg injections cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Ziihera® 300 mg injections be available in SAARC countries?

Apart from Gulf countries, Ziihera® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Ziihera® injections in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Ziihera® 300 mg injections online in India?

Yes, one can buy Ziihera 300 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Ziihera® injections through legal channels.

What are the storage conditions of Ziihera® 300 mg injections?

Store the vials in a refrigerator at 2-8°C (36-46°F) in the original carton until the time of reconstitution. Do not freeze it.